tokens: The Thrombolysis in Myocardial Infarction ( TIMI ) Phase II Trial randomized 3 , 339 patients to either an invasive ( INV , n = 1 , 681 ) or a conservative ( CON , n = 1 , 658 ) strategy after intravenous recombinant tissue - type plasminogen activator ( rt - PA ) for acute myocardial infarction .